Virulence hierarchies within the <i>Mycobacterium tuberculosis</i> complex

S Sarah N. Danchuk (Department of Microbiology and Immunology, McGill University) S Shannon C. Duffy (Department of Epidemiology of Microbial Diseases, Yale School of Public Health) J Jaryd Sullivan (Department of Molecular Biology and Centre for Computational and Integrative Biology, Massachusetts General Hospital) S Syed Beenish Rufai (Department of Neuroscience, University of Lethbridge) F Fiona A. McIntosh (Infectious Disease and Immunity in Global Health Program, Research Institute of the McGill University Health Centre) A Andréanne Lupien (Department of Microbiology and Immunology, McGill University) L Luke B. Harrison (Infectious Disease and Immunity in Global Health Program, Research Institute of the McGill University Health Centre) H Hojjat Ghasemi Goojani (Infectious Disease and Immunity in Global Health Program, Research Institute of the McGill University Health Centre) L Lorne Taylor (Infectious Disease and Immunity in Global Health Program, Research Institute of the McGill University Health Centre) Y Yuhong Wei (Goodman Cancer Institute, McGill University) P Philippe Joubert R Rasmus Mortensen (Center for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut) J Jeffrey M. Chen (Mycobacterial Pathogenesis and Tuberculosis Research Laboratory, Vaccine and Infectious Disease Organization, University of Saskatchewan) N Nirajan Niroula (Mycobacterial Pathogenesis and Tuberculosis Research Laboratory, Vaccine and Infectious Disease Organization, University of Saskatchewan) R Robin Stevens (Mycobacterial Pathogenesis and Tuberculosis Research Laboratory, Vaccine and Infectious Disease Organization, University of Saskatchewan) C Carla Norleen (Mycobacterial Pathogenesis and Tuberculosis Research Laboratory, Vaccine and Infectious Disease Organization, University of Saskatchewan) V Vivek Kapur (Department of Animal Science and the Huck Institutes of the Life Sciences, The Pennsylvania State University) M Marcel A. Behr (Department of Microbiology and Immunology, McGill University)

Abstract

The Mycobacterium tuberculosis complex (MTBC) includes M. tuberculosis ( M. tb ), the primary cause of human tuberculosis, M. bovis, the classical zoonotic pathogen and cause of bovine tuberculosis, and M. orygis, a recently recognized multihost pathogen. Given that M. tb, M. bovis, and M. orygis pose significant threats to the health of humans and animals, we sought to understand fundamental differences in pathogenicity among these closely related organisms. Building upon historical observations, we conducted a comparative virulence assessment of these pathogens using both bovine and murine infection models. Holstein calves were infected via aerosol with M. tb, M. bovis, or M. orygis , and pathology was analyzed through macroscopic and microscopic assessments of lungs and lymph nodes, along with quantitative tissue bacterial burden measurements. In C57BL/6 mice, we compared virulence using three readouts, namely survival, lethal dose determination, and detailed pathological assessments. Despite genomic similarity, animal-adapted MTBCs consistently showed dramatically enhanced virulence compared to M. tb with distinct immunopathology and, in the murine model, mortality within 24 days. Using gene disruption studies guided by proteomic comparisons, we determined that these infection outcomes were dependent on shared (ESAT-6) and lineage-associated (MPT70) virulence factors, the route of infection, and prior infection or immunization. Our findings reveal unexpected virulence hierarchies within the MTBC, with fundamental and translational implications for tuberculosis research.

Article Details

Volume / Issue Vol. 122, Issue 42
Published October 21, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (18)

S

Sarah N. Danchuk

Department of Microbiology and Immunology, McGill University

S

Shannon C. Duffy

Department of Epidemiology of Microbial Diseases, Yale School of Public Health

J

Jaryd Sullivan

Department of Molecular Biology and Centre for Computational and Integrative Biology, Massachusetts General Hospital

S

Syed Beenish Rufai

Department of Neuroscience, University of Lethbridge

F

Fiona A. McIntosh

Infectious Disease and Immunity in Global Health Program, Research Institute of the McGill University Health Centre

A

Andréanne Lupien

Department of Microbiology and Immunology, McGill University

L

Luke B. Harrison

Infectious Disease and Immunity in Global Health Program, Research Institute of the McGill University Health Centre

H

Hojjat Ghasemi Goojani

Infectious Disease and Immunity in Global Health Program, Research Institute of the McGill University Health Centre

L

Lorne Taylor

Infectious Disease and Immunity in Global Health Program, Research Institute of the McGill University Health Centre

Y

Yuhong Wei

Goodman Cancer Institute, McGill University

P

Philippe Joubert

R

Rasmus Mortensen

Center for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut

J

Jeffrey M. Chen

Mycobacterial Pathogenesis and Tuberculosis Research Laboratory, Vaccine and Infectious Disease Organization, University of Saskatchewan

N

Nirajan Niroula

Mycobacterial Pathogenesis and Tuberculosis Research Laboratory, Vaccine and Infectious Disease Organization, University of Saskatchewan

R

Robin Stevens

Mycobacterial Pathogenesis and Tuberculosis Research Laboratory, Vaccine and Infectious Disease Organization, University of Saskatchewan

C

Carla Norleen

Mycobacterial Pathogenesis and Tuberculosis Research Laboratory, Vaccine and Infectious Disease Organization, University of Saskatchewan

V

Vivek Kapur

Department of Animal Science and the Huck Institutes of the Life Sciences, The Pennsylvania State University

M

Marcel A. Behr

Department of Microbiology and Immunology, McGill University